BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11723044)

  • 1. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.
    Spranger J; Osterhoff M; Reimann M; Möhlig M; Ristow M; Francis MK; Cristofalo V; Hammes HP; Smith G; Boulton M; Pfeiffer AF
    Diabetes; 2001 Dec; 50(12):2641-5. PubMed ID: 11723044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
    Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid.
    Kim SY; Mocanu C; Mcleod DS; Bhutto IA; Merges C; Eid M; Tong P; Lutty GA
    Exp Eye Res; 2003 Oct; 77(4):433-45. PubMed ID: 12957143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization.
    Al-Shabrawey M; Mussell R; Kahook K; Tawfik A; Eladl M; Sarthy V; Nussbaum J; El-Marakby A; Park SY; Gurel Z; Sheibani N; Maddipati KR
    Diabetes; 2011 Feb; 60(2):614-24. PubMed ID: 21228311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
    Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
    J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
    Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
    Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Yokoi M; Yamagishi S; Saito A; Yoshida Y; Matsui T; Saito W; Hirose S; Ohgami K; Kase M; Ohno S
    Br J Ophthalmol; 2007 Jul; 91(7):885-7. PubMed ID: 17301120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium--derived factor in brown norway and sprague dawley rats contributing to different susceptibilities to retinal neovascularization.
    Gao G; Li Y; Fant J; Crosson CE; Becerra SP; Ma JX
    Diabetes; 2002 Apr; 51(4):1218-25. PubMed ID: 11916948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor.
    Penn JS; McCollum GW; Barnett JM; Werdich XQ; Koepke KA; Rajaratnam VS
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):405-14. PubMed ID: 16384991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
    Simó R; Carrasco E; García-Ramírez M; Hernández C
    Curr Diabetes Rev; 2006 Feb; 2(1):71-98. PubMed ID: 18220619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.
    Chernykh VV; Varvarinsky EV; Smirnov EV; Chernykh DV; Trunov AN
    Indian J Ophthalmol; 2015 Jan; 63(1):33-6. PubMed ID: 25686060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.
    Abu El-Asrar AM; Imtiaz Nawaz M; Kangave D; Siddiquei MM; Geboes K
    Mediators Inflamm; 2012; 2012():493043. PubMed ID: 23055574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. a pilot study.
    Boehm BO; Lang G; Feldmann B; Kurkhaus A; Rosinger S; Volpert O; Lang GK; Bouck N
    Horm Metab Res; 2003 Jun; 35(6):382-6. PubMed ID: 12920663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis.
    Eichler W; Yafai Y; Keller T; Wiedemann P; Reichenbach A
    Exp Cell Res; 2004 Sep; 299(1):68-78. PubMed ID: 15302574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
    Yoshida Y; Yamagishi S; Matsui T; Jinnouchi Y; Fukami K; Imaizumi T; Yamakawa R
    Diabetes Metab Res Rev; 2009 Oct; 25(7):678-86. PubMed ID: 19685553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Nakamura S; Mimura T; Eguchi S; Noma H; Hori S
    Ophthalmology; 2006 Feb; 113(2):294-301. PubMed ID: 16406543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.